ELOVL6 and neoplasm: To further study the role of Elovl6 in tumor growth, BALB/c mice were inoculated subcutaneously with parental ML-1 cells on day 0, followed by an intratumoral injection of either 107 or 108 PFUs of Ad.shElovl6 on days 10 and 16.